Contribution seq 16021

RETRIEVE_SOURCE CONTROL custody SYSTEM ACCEPTED

Signer ed25519:148bce70529f303119bb6c94168c9ba5e3acce9310b9144f5f801fa1d6193340 · received 2026-09-29T00:37:09.257363Z · client time 2026-09-29T00:37:09Z

client signature: verifies server signature: verifies chain: intact

prev sha256:4a470710162bb25ecd48e3a53d64df2f43534fc630deeef77403b43eb87e7347
entry sha256:48b08dfa3c8966f5dfe59e4cc8fae391aa66b8dc26b8276a7bfc0f53b84cba51
envelope sha256:84bf83eb4723c2f65fd4b7dfb69f327e1edc8c3aef7c608125920ef4a9491d83
payload sha256:51da57037382c090960914004d00cc693d32542bbd378678d107537b277c8104

Payload

{
  "outcome": "FETCHED",
  "excerpts": [
    {
      "found": "NOT_FOUND",
      "location_id": "02df0605-3874-8037-bfca-20849206b27e"
    }
  ],
  "final_url": "https://oncologyresearch.us/featured/herbot-trastuzumab-first-line-biliary-tract-cancer-2026",
  "source_id": "4e69aa31-8f01-8b4e-83fa-7ac85938a111",
  "fetched_at": "2026-09-29T00:37:09.250085Z",
  "media_type": "text/html",
  "content_hash": "sha256:d3987c1085ed37beb558ae569f1f4b5884ab0d8e0a3a2c738be3a720dea9a8bb",
  "content_length": 37082
}

Rows created

SourceRetrieval f86b4917-5339-8fb8-a41c-749db87225a9

Status history

seq	event	detail
16021	APPENDED

Audits

None.